The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity
Abstract The size of nanoliposome‐encapsulated drugs significantly affects their therapeutic efficacy, biodistribution, targeting ability, and toxicity profile for the cancer treatment. In the present study, the biodistribution and anti‐tumoral activity of PEGylated liposomal Doxorubicin (PLD) formu...
Saved in:
Main Authors: | Saba Dadpour, Amin Mehrabian, Mahdieh Arabsalmani, Elaheh Mirhadi, Anis Askarizadeh, Mohammad Mashreghi, Mahmoud Reza Jaafari |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-09-01
|
Series: | IET Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1049/nbt2.12094 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice
by: Amin Mehrabian, et al.
Published: (2023-04-01) -
A multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast cancer
by: Jingshu Wang, et al.
Published: (2025-01-01) -
Electrostatic properties of human germlines and biodistribution of small biologics
by: Leticia Maria De Souza Cordeiro, et al.
Published: (2024-12-01) -
Synthesis and Characterization of PEGylated Liposomes and Nanostructured Lipid Carriers with Entrapped Bioactive Triterpenoids: Comparative Fingerprints and Quantification by UHPLC-QTOF-ESI<sup>+</sup>-MS, ATR-FTIR Spectroscopy, and HPLC-DAD
by: Carmen Socaciu, et al.
Published: (2024-12-01) -
Iron(III)–Quercetin Complex: In Vivo Acute Toxicity and Biodistribution of Novel MRI Agent
by: Innuan P, et al.
Published: (2025-01-01)